Recombinant NKG2A (Monalizumab Biosimilar) antibody

Catalog No. ABIN7597834

The Humanized Chimeric anti-NKG2A (Monalizumab Biosimilar) antibody has been validated for . It is suitable to detect NKG2A (Monalizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant NKG2A (Monalizumab Biosimilar) antibody (ABIN7597834)

Target: NKG2A (Monalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This NKG2A (Monalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-NKG2A (Monalizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Monalizumab Biosimilar Antibody

Specificity: KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159 antigen-like family member A, CD159a, NK cell receptor A, NKG2A

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 6.65 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for NKG2A (Monalizumab Biosimilar)

Target: NKG2A (Monalizumab Biosimilar)

Alternative Name: Monalizumab Biosimilar

Target Type: Biosimilar

Background: KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159 antigen-like family member A, CD159a, NK cell receptor A, NKG2A

UniProt: P26715

CAS-No: 1228763-95-8